A national audit of the management pathways for new HIV diagnoses

  • on behalf of the BHIVA Audit and Standards Subcommittee

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    The British HIV Association recommends that new diagnoses be reviewed by an HIV specialist within two weeks. NHS England outcome measures include the proportion of new diagnoses commencing antiretroviral therapy (ART) within 91 days. We aimed to review the extent to which these recommendations were followed, to explore the topics discussed with new diagnoses, and to identify reasons behind delayed ART initiation. UK specialist HIV services were invited to retrospectively review the notes of their last 40 new diagnoses over a 15-month period. One-hundred and thirty-two services provided data for 2281 eligible individuals. Most new diagnoses were reviewed by a specialist within two weeks (67.7%) and were commenced on ART within 91 days (83%), however, there were some concerning delays in those tested at home and in general practice. Partner notification and treatment benefits were discussed with most individuals, unlike the availability of community support and U = U (“undetectable equals untransmittable”). Lengthy delays in ART initiation were mostly due to individuals initially declining ART or missing appointments. Our findings suggest a need for more streamlined pathways into HIV care, review of new diagnoses who have not commenced ART within 8 weeks, and protocol development to ensure discussion of relevant topics.

    Original languageEnglish
    Pages (from-to)710-717
    Number of pages8
    JournalInternational Journal of STD and AIDS
    Volume32
    Issue number8
    Early online date3 Feb 2021
    DOIs
    Publication statusPublished - 1 Jul 2021

    Bibliographical note

    Funding Information:
    The research was supported, in part, by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at University College London in partnership with Public Health England (PHE), in collaboration with London School of Hygiene & Tropical Medicine (LSHTM).

    Publisher Copyright:
    © The Author(s) 2021.

    Keywords

    • Europe
    • antiretroviral therapy
    • combination antiretroviral therapy
    • diagnosis
    • human immunodeficiency virus

    Fingerprint

    Dive into the research topics of 'A national audit of the management pathways for new HIV diagnoses'. Together they form a unique fingerprint.

    Cite this